The Prognostic Value of the Advanced Lung Cancer Inflammation Index on Disease-Free Survival in Patients with Gastric Cancer Receiving Neoadjuvant Chemotherapy
A low pre-treatment ALI score independently predicts shorter DFS in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy and surgery, warranting further prospective validation.